Skip to content

Enzalutamide Impurity E

Enzalutamide Impurity E

Product Description
CAT No.
ALN-E015016
CAS No.
NA
Mol. F.
C28H16F7N5O2S
Mol. Wt.
619.5
Stock
Please Inquire
RFQ
Chemical Name : N-[4-cyano-3-(trifluoromethyl) phenyl]-4-{3-[4-cyano-3-(trifluoromethyl) phenyl]-5, 5-dimethyl- 4-oxo-2-thioimidazol-1-yl}- 2-fluorobenzamide
Smiles : O=C(NC1=CC=C(C#N)C(C(F)(F)F)=C1)C2=CC=C(N(C(N3C4=CC=C(C#N)C(C(F)(F)F)=C4)=S)C(C)(C)C3=O)C=C2F
Inchi : InChI=1S/C10H7F3N2OS/c1-16-9(17)15-7-3-2-6(5-14)8(4-7)10(11,12)13/h2-4H,1H3,(H,15,17)

Structural elucidation of the impurities in Enzalutamide bulk drug and the development, validation of corresponding HPLC method

Xingling Mab , Wentao Zhoua , Qiaogen Zoua,*, Pingkai OuyangnJournal of Pharmaceutical and Biomedical Analysis Volume 131, 30 November 2016, Pages 436-443

Crystal Forms of Enzalutamide and a Crystal Engineering Route to Drug Purification

, Pingkai Ouyang – Journal of Pharmaceutical and Biomedical Analysis Volume 131, 30 November 2016, Pages 436-443

Quantitative Study of\xa0Impurities in\xa0Enzalutamide and\xa0Identification, Isolation, Characterization of\xa0Its Four Degradation Products Using HPLC, Semi-preparative LC, LC/ESI–MS and\xa0NMR Analyses

Lucia Maini, Dario Braga, Francesco Farinella, Elisa Melotto, Massimo Verzini, Roberto Brescello, Ivan Michieletto, and Ilaria Munari – Cryst. Growth Des. 2018, 18, 7, 3774–3780

Request For Quotation

Related Products